StockWatch
·

BACIL PHARMA LTD. Q4 FY26 Results

BACPHARQ4 FY26 Results
Filing
MetricValue (₹ Cr)Q3 FY26Q4 FY25
Revenue0.00
Total Income0.1175.8%29.3%
Expenditure0.07194.5%3.2%
PBT0.040.8%151.0%
Net Profit0.621485.7%3910.3%
OPM—
NPM100.00%39.22pp82.33pp
EPS0.441366.7%120.0%
View full financials

Informational and educational content only. Not investment advice.